BG Medicine, Inc.  

(Public, OTCMKTS:BGMD)   Watch this stock  
Find more results for NASDAQ:BGMD
-0.045 (-18.07%)
May 27 - Close
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range 0.20 - 0.25
52 week 0.17 - 3.28
Open 0.25
Vol / Avg. 26,576.00/44,259.00
Mkt cap 2.33M
P/E     -
Div/yield     -
EPS -0.74
Shares 11.37M
Beta 2.52
Inst. own 8%
Apr 29, 2016
Q4 2015 BG Medicine Inc Earnings Release

Key stats and ratios

Q4 (Dec '15) 2015
Net profit margin -311.03% -338.63%
Operating margin -311.03% -295.66%
EBITD margin - -290.10%
Return on average assets -131.82% -144.06%
Return on average equity - -
Employees 5 -
CDP Score - -


880 Winter St Ste 210
WALTHAM, MA 02451-1465
United States - Map
+1-781-8901199 (Phone)
+1-302-6365454 (Fax)

Website links


BG Medicine, Inc. is a commercial-stage company that is focused on the development and delivery of diagnostic solutions to aid in the clinical management of heart failure and related disorders. The Company's BGM Galectin-3 Test is an in vitro diagnostic device that quantitatively measures galectin-3 levels in blood plasma or serum for use as an aid in assessing the prognosis of chronic heart failure. The Company is focused on preparing for the anticipated United States market introduction of galectin-3 automated testing by its automated diagnostic instrument manufacturing partners by providing support to clinical research studies that seek to affirm the potential clinical utility and impact of galectin-3 testing in heart failure and related disorders, by expanding its BGM Galectin-3 Test's indication for use and by continuing to support and promote the publication of the results of clinical research studies.

Officers and directors

Paul R. Sohmer M.D. President, Chief Executive Officer, Director
Age: 66
Stephen P. Hall Chief Financial Officer, Executive Vice President, Treasurer
Age: 64
Aram Adourian Ph.D. Senior Vice President, Chief Scientific Officer
Age: 45
Jeffrey R. Luber J.D. Director
Age: 49
James F. O Connor CPA Director
Age: 74
Harry W. Wilcox III Director
Age: 61
Stelios B. Papadopoulos Ph.D. Independent Director
Age: 67